박지은 교수 연구실
article|
gold
·인용수 5
·2024
A preclinical and phase I clinical study of ex vivo-expanded amyloid beta-specific human regulatory T cells in Alzheimer’s disease
Hyejin Yang, Min Soo Byun, Na-Yeon Ha, Juwon Yang, Seon‐Young Park, Jee Eun Park, Dahyun Yi, Young‐Tae Chang, Woo Sang Jung, Jae Yoon Kim, Jinsung Kim, Dong Young Lee, Hyunsu Bae
IF 7.5Biomedicine & Pharmacotherapy
초록
Title: A Study of Possibility of Using Regulatory T Cells (VT301) for Treatment of Alzheimer's Disease, ClinicalTrials.gov NCT05016427, Study approval date: Ministry of Food and Drug Safety of the Republic of Korea (MFDS) - August 31st, 2020, Institutional Review Board (IRB) of Seoul National University Hospital, Republic of Korea - September 29th, 2020, The date of first patient enrollment: December 7th, 2020. https://clinicaltrials.gov/study/NCT05016427.
키워드
Ex vivoAmyloid (mycology)DiseaseBETA (programming language)MedicineIn vivoAmyloid betaNeurosciencePathologyBiology